Drug trial victim permanently disabled while drug companies continue to use humans as guinea pigs

Wednesday, June 28, 2006 by: NewsTarget
Tags: drug trials, health news, Natural News

https://www.naturalnews.com/019495_drug_companies.html

Tweet

---

Wilson had a severe reaction within moments of being injected with the experimental drug TGN1412 -- meant to treat rheumatoid arthritis, leukemia and multiple sclerosis. He spent four months in an intensive care unit and suffered through heart, kidney and liver failure, as well as pneumonia and septicemia -- a severe blood infection. He also suffered from frostbite-like symptoms, which turned his toes and some of his fingers black, requiring amputation.

Wilson has given up on being a plumber and must now rely on a wheelchair. After his amputation surgery, he will require months of physical therapy to learn to walk without toes.

"I wouldn't want anyone else to go through this -- even people that I'd call enemies," Wilson said. "It's undignified."

The six drug trial victims -- all of whom have been released from the hospital, except Wilson -- are now negotiating compensation settlements with Paraxel, the drug firm that makes TGN1412.

Meanwhile, drug companies continue to use humans as guinea pigs for medical experiments, especially the poor. The history of medical experimentation on humans is detailed in two NewsTarget investigative reports: Read part one. Read part two.

###